In the original article, there was an error in the name of Traditional Chinese Medicine throughout the article. The name was displayed as “QiShenYiQi Dripping Pills (T101)” or “QSYQ (T101)”. The corrected name is “QiShenYiQi Dripping Pills” or “QSYQ”. The code number T101 has been deleted in the title and Figure 1.
FIGURE 1

The flowchart of the study.
The corrected title appears below.
“Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities”.
The corrected Figure 1 and its caption “The flowchart of the study.” appear below.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Statements
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
heart failure, QSYQ, SHR, network pharmacology, metabolomics
Citation
Zhang J, Yang Z, Jia X, Li X, Wang X, Rong H, Liang Y, Zeng W, Jia W and Ma X (2022) Corrigendum: Integrated network pharmacology and metabolomics to reveal the mechanism of QiShenYiQi Dripping Pills against cardiac structural and functional abnormalities. Front. Pharmacol. 13:1080645. doi: 10.3389/fphar.2022.1080645
Received
26 October 2022
Accepted
04 November 2022
Published
21 November 2022
Volume
13 - 2022
Edited and reviewed by
Wei Deng, Renmin Hospital of Wuhan University, China
Updates
Copyright
© 2022 Zhang, Yang, Jia, Li, Wang, Rong, Liang, Zeng, Jia and Ma.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Wei Jia, weijia1@hkbu.edu.hk; Xiaohui Ma, maxiaohui@tasly.com
This article was submitted to Cardiovascular and Smooth Muscle Pharmacology, a section of the journal Frontiers in Pharmacology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.